To keep drug prices high, pharma has been piling up the patents
Add-on patents have increased drug patent periods from two years to over six.
Sourcing & attribution. Newseze provides AI-curated summaries, narrative framing, and editorial analysis. The underlying reporting was contributed by Ars Technica; tap “Open original source” above to read their full reporting and support the contributing newsroom directly.
Newseze's algorithm reads the story and answers your question — calmly, factually, with source attribution. No comments, no flame wars — just answers.
No questions yet. Be the first.
Answers reflect Newseze's editorial framework applied under fair use (17 U.S.C. § 107). Not financial, legal, medical, or tax advice. Hate speech and racial slurs are blocked.
Related stories
Why it mattersThe acquisition will see World Labs founder Fei-Fei Li join AMD as executive vice president and chief scientist.
By Chella·47m ago
Why it mattersThe bureau has not yet publicly confirmed a breach, but has told its agents that their personal information and Social Security numbers were exposed.
By Chella·6h ago
Why it mattersKimi Antonelli could not repeat his Monza magic after a crash in qualifying.
By Chella·3h ago
Why it mattersIn a chaotic few months, OpenAI has demonstrated it can do two things with remarkable consistency: make impressive breakthroughs in mathematics, then colossally screw up announcing them. OpenAI is now trying to do better…
In a chaotic few months, OpenAI has demonstrated it can do two things with remarkable consistency: make impressive breakthroughs in mathematics, then colossally…
By Chella·4h ago